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Objective
The relative importance of insulin resistance and hyperglycemia to the development of atherosclerosis remains unclear. Furthermore, adiposity may be responsible for observed associations.
Our aim was to study the relative contributions of adiposity, insulin resistance and hyperglycemia to subclinical atherosclerosis.
Methods
In this cross-sectional analysis of the Netherlands Epidemiology of Obesity (NEO) study, a cohort of persons of 45-65 years, BMI, waist circumference (WC), fasting glucose (FPG), HbA 1c and insulin concentrations were measured and the revised HOMA-IR was calculated. The carotid intima-media thickness (cIMT) was measured by ultrasound. We performed linear regression analyses between standardized values of FPG, HbA 1c , HOMA-IR, BMI, WC with cIMT, and subsequently included age, sex, ethnicity, education and smoking, HOMA-IR, HbA 1c and FPG, BMI and WC in the models.
Results
After exclusion of participants with glucose lowering therapy (n=356) or missing data (n=252), this analysis included 6,065 participants, 43% men, and mean (SD) cIMT of 616 (92) μm. Differences in cIMT (95% CI) per SD were: FPG: 16 (10,21); HbA 1c : 12 (7,16); HOMA-IR: 11 (6,16) μm.
These associations attenuated after adjustments, and attenuated most strongly after adjustment for WC. Differences in cIMT (95% CI) per SD in the full model were: FPG: 4 (0,7); HbA 1c : 2 (-1,5); HOMA-IR: 0 (-3,3); BMI 16 (13,19) ; WC: 18 (14, 21) μm.
Conclusion
In middle-aged individuals, we observed similar contributions of insulin resistance and hyperglycemia to subclinical atherosclerosis. These contributions were largely explained by abdominal adiposity, emphasizing the importance of weight management.
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IntroduCtIon
Type 2 diabetes increases the risk of cardiovascular disease 2-to 3-fold [12, 13] . Both insulin resistance and hyperglycemia may promote atherosclerosis [16, 17] . However, the relative importance of hyperglycemia and insulin resistance to the development of atherosclerosis remains unclear.
Experimental studies have identified differential contributions of hyperglycemia and insulin resistance to the development of atherosclerosis. Insulin resistance may lead to atherosclerosis through various mechanisms, including dyslipidemia and inflammation [16] . Hyperglycemia may contribute to endothelial dysfunction by several mechanisms, including oxidative stress, increased production of advanced glycation endproducts and alterations in glycocalyx composition [17, 120] . However, randomized controlled trials in individuals with pre-diabetes and type 2 diabetes have not shown an effect of intensive glycemic control (i.e. lowering HbA 1c concentration) on the incidence of cardiovascular events [121, 122] . These results suggest that the contribution of hyperglycemia to the development of atherosclerosis may be limited.
Observational studies in persons without glucose lowering therapy have shown that measures of insulin resistance and glucose concentrations were associated with carotid intimamedia thickness (cIMT) [20, 22, 23] , a marker of subclinical atherosclerosis, and cardiovascular disease [13, 107, 123] . These studies, however, have not distinguished the contributions of hyperglycemia and insulin resistance. Moreover, adiposity may result in insulin resistance, consequential hyperglycemia and atherosclerosis and may therefore be responsible for observed associations. We hypothesize that observed associations between insulin resistance, hyperglycemia and atherosclerosis can be explained by adiposity (These hypothetical pathways are depicted in Figure 1 ). Therefore, the aim of this study is to investigate the relative contributions of adiposity, insulin resistance and hyperglycemia to subclinical atherosclerosis, in a cohort of men and women without glucose lowering therapy.
Adiposity
materIaLs and methods
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective cohort study in individuals aged 45-65 years, with an oversampling of persons with a BMI of 27 kg/m 2 or higher. This cohort was designed to prospectively study pathways that lead to disease in persons with overweight or obesity. The present study is a cross-sectional analysis of the baseline measurements of the participants included in the NEO study from the start at September 3, 2008 until the end at September 28, 2012. Detailed information about the study design and data collection has been described elsewhere [77] . Men and women aged between 45 and 65 years with a self-reported BMI of 27 kg/m 2 or higher living in the greater area of Leiden (in the West of The Netherlands) were eligible to participate in the NEO study.
In addition, all inhabitants aged between 45 and 65 years from one municipality (Leiderdorp)
were invited, irrespective of their BMI.
Prior to the NEO study visit, participants completed a questionnaire about demographic and clinical data and fasted for at least 10 hours. Participants came to the research site in the morning to undergo several baseline measurements including anthropometric measurements, blood sampling and a cIMT measurement. For the present analysis, we excluded participants who used oral hypoglycemic agents or insulin in the month prior to the study visit, in addition to participants with missing data.
The study was approved by the medical ethics committee of the Leiden University Medical Center (LUMC) and all participants gave written informed consent.
Data collection
Participants reported ethnicity by self-identification in eight categories which we grouped into white (reference) and other. Tobacco smoking was reported in the three categories current smoker, former smoker, never smoker (reference). Highest level of education was reported in 10 categories according to the Dutch education system and grouped into high versus low education (reference). Participants reported their medical history of diabetes and cardiovascular diseases. Pre-existing cardiovascular disease was defined as myocardial infarction, angina, congestive heart failure, stroke, or peripheral vascular disease. In addition, all use of medication in the month preceding the study visit was recorded. At the study site, height and weight were measured without shoes and with precision of 0.1 cm/kg and 1 kilogram was subtracted from the weight for clothing. BMI was calculated by dividing the weight in kilograms by the height 3 in meters squared. Waist circumference was measured between the border of the lower costal margin and the iliac crest with the precision of 0.1 cm. We used BMI as a measure of overall adiposity and waist circumference as a measure of abdominal adiposity.
Measures of insulin resistance and glycemic control
Fasting blood samples were drawn from the antecubal vein after 5 min rest of the participant. 
Carotid intima-media thickness
The cIMT was measured in the far wall of the left and right common carotid arteries (CCA's), along a 15 mm long section 10 mm, proximal of the bifurcation, and in recumbent position. A 7.5-10 MHz linear-array transducer (Art.Lab version 2.1, Esaote, Maastricht, The Netherlands) in B-mode setting was used to visualize the distal CCA and an online wall track system was used to detect the lumen-intima and media-adventitia boundaries. CIMT was measured in three predefined angles per side (180,135 and 90° for the right CCA and 180, 225 and 270° for the left CCA) during six heartbeats. We calculated the mean cIMT for each participant (referred to as cIMT) by averaging all 36 cIMT measurements within each individual.
Statistical analyses
In the NEO study there is an oversampling of individuals with a BMI of 27 kg/m 2 or higher. (Figures 3a and 3b) . Of all confounding variables, association between FPG, HbA 1c , and cIMT attenuated most strongly after adjustment for waist circumference.
The crude association of one standard deviation of HOMA-IR (0.81 units) of 11 μm cIMT (95% CI: 6, 16) attenuated to 9 μm (95% CI: 5, 12) after adjustment for age, sex, ethnicity, education, and tobacco smoking and to 6 μm (95% CI: 3, 10) after adjustment for HbA 1c and FPG. After additional adjustment for both BMI and waist circumference the cIMT difference was 0 μm (95% One standard deviation of waist circumference (men: 11 cm; women: 13 cm) was associated with 19 (95% CI: 17, 21) μm cIMT. These associations attenuated after adjustment for age, sex, ethnicity, education, and tobacco smoking (BMI: 17 μm, 95% CI: 14, 20; waist circumference: 19 μm, 95% CI: 16, 22) (Figure 3) . After additional adjustment for FPG, HbA 1c , and HOMA-IR, the cIMT differences was 16 μm cIMT (95% CI: 13, 19) for BMI and 18 μm cIMT (95% CI: 14, 21) for waist circumference. The differences in cIMT were similar when we adjusted separately for FPG and HbA 1C and HOMA-IR (Figures 3d and 3e) .
After exclusion of participants with pre-existing cardiovascular disease results were similar (data not shown).
dIsCussIon
In this population-based study of men and women without glucose lowering medication, we observed that both insulin resistance and hyperglycemia remained associated with cIMT after mutual adjustment. Importantly, abdominal adiposity largely explained these associations.
Several studies have investigated associations between insulin resistance, hyperglycemia and cIMT, a marker of subclinical atherosclerosis. The correlation coefficients between HbA 1C , FPG, HOMA-IR, BMI, waist circumference and cIMT from our study were within the range of correlation coefficients observed in previous studies [20, 22, 23, [130] [131] [132] [133] . However, relative contributions of hyperglycemia, insulin resistance and adiposity to the development of atherosclerosis were not identified in these studies. A recent study in 60 middle-aged individuals without diabetes concluded that the association between plasma glucose concentrations and cardiovascular risk was mainly explained by insulin resistance [134] . However, after adjustment for insulin sensitivity FPG remained associated with the cardiovascular risk score. In our study of 6,065 participants, in which we assessed a clinical parameter of subclinical atherosclerosis instead of a risk calculator, both insulin resistance and glucose concentrations remained associated with the cIMT after mutual adjustment. These associations were of similar strength, suggesting that both play a role in the development of atherosclerosis. However, in our study, waist circumference was most strongly associated with the cIMT, and largely explained the association of hyperglycemia with cIMT and completely explained the association of insulin resistance with cIMT. This implies that abdominal adiposity is for a large part responsible for the development of insulin resistance, hyperglycemia and subclinical atherosclerosis.
Strengths of this study are the large study population and the availability of a clinical parameter of atherosclerosis, information on measures of glycemic control, potential confounding variables, and of waist circumference as a measure of abdominal adiposity besides BMI.
This study also has some limitations that need to be considered. We assessed insulin resistance using the HOMA-IR instead of using a gold standard measurement, the hyperinsulinemic euglycemic clamp. However, the application of hyperinsulinemic euglycemic clamps in large epidemiologic studies is often not feasible. HOMA-IR is a surrogate measure of insulin resistance and may therefore not account for the total effect of insulin resistance [81] . Since waist circumference is strongly associated with insulin resistance [135] , adjustment for waist circumference in addition to HOMA-IR may have resulted in a more complete adjustment for insulin resistance. However, due to the observational cross-sectional nature of our analyses, residual confounding may remain.
Data from experimental studies have shown that both insulin resistance and hyperglycemia can promote the development of atherosclerosis [16, 17] . Whereas insulin resistance seems to be involved in both early atherosclerosis and advanced plaque progression (Figure 1, path hyperglycemia and subclinical atherosclerosis were weak, one cannot rule out the possibility that small effects can accumulate over time.
In our study, waist circumference most strongly explained the association between insulin resistance, hyperglycemia and subclinical atherosclerosis, implying underlying pathways between abdominal adiposity and atherosclerosis beyond pathways via insulin resistance and glucose. We furthermore observed that the association between waist circumference and subclinical atherosclerosis attenuated slightly after adjustment for hyperglycemia and insulin resistance, suggesting that it is partly mediated through insulin resistance and hyperglycemia, but largely through other mechanisms. Associations attenuated to the same extent when adjusting for insulin resistance and hyperglycemia together and separately, suggesting that both reflect the same mechanism.
Observational studies support that abdominal adiposity is a better marker of cardiometabolic risk and mortality than overall adiposity [137] . Adipose tissue is an endocrine organ secreting pro-inflammatory cytokines and non-esterified fatty acids (NEFAs) [49] , that may promote the development of insulin resistance (Figure 1 , path C) and atherosclerosis (Figure 1, path A) via mechanisms of inflammation and oxidative stress [17, 138] . Adipose tissue may therefore promote the development of atherosclerosis through insulin resistance (Figure 1 , path CB)
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and hyperglycemia (Figure 1 , path CDE), but also directly by mechanism such as inflammation, dyslipidemia and hypertension (Figure 1 , path A) [138] . Especially intra-abdominal adipose tissue is a major source of adipokines and NEFAs [139] , and waist circumference has been shown to be an adequate marker of abdominal adiposity [140] . Several weight loss studies have shown that cardiometabolic improvements were related to the extent of intra-abdominal adipose tissue loss [141, 142] . Therefore, health benefits can be gained from weight loss interventions in individuals with abdominal adiposity.
In conclusion, in middle-aged individuals without glucose lowering medication we observed similar contributions of insulin resistance and hyperglycemia to the development of subclinical atherosclerosis. These contributions were to a large extent explained by abdominal adiposity, emphasizing the importance of weight management and prevention of weight gain in adulthood.
